{
    "code": "01019129",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01019129",
    "time": "2020-01-31 03:58:57",
    "許可證字號": "衛署藥製字第019129號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/12\/25",
    "發證日期": "79\/09\/10",
    "許可證種類": "製　劑",
    "舊證字號": "01019129",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101912903",
    "中文品名": "利伯達膠囊（禮多盼）",
    "英文品名": "LEVODOPA CAPSULES &quot;F.S.&quot;",
    "適應症": "帕金森氏症、腦炎後、動脈硬化或特發性所引起之肌肉震顫或痙攣",
    "劑型": "130膠囊劑",
    "包裝": "4-1000粒瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "6203281696  富生醫藥生技股份有限公司",
        "申請商地址": "臺中市南屯區工業區23路19號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002900",
            "成分名稱": "LEVODOPA",
            "含量描述": "",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ]
}